Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
21.38
-0.35 (-1.61%)
At close: Jul 19, 2024, 4:00 PM
21.35
-0.03 (-0.14%)
After-hours: Jul 20, 2024, 12:57 PM EDT
Company Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A.
is a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A.
| Country | Italy |
| Founded | 1949 |
| IPO Date | Jul 16, 2021 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 5,634 |
| CEO | Franco Stevanato |
Contact Details
Address: Piombino Dese (Pd) Via Molinella, 17 Padua, L6 35017 Italy | |
| Phone | 39 049 9318173 |
| Website | stevanatogroup.com |
Stock Details
| Ticker Symbol | STVN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| IPO Price | $21.00 |
| CIK Code | 0001849853 |
| CUSIP Number | T9224W109 |
| ISIN Number | IT0005452658 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Franco Moro | Chief Executive Officer and Director |
| Franco Stevanato | Executive Chairman |
| Marco Dal Lago | Chief Financial Officer |
| Ugo Gay | Chief Operations Officer |
| Lorenzo Bendinelli | Chief Information Officer |
| Lisa Miles | Senior Vice President of Investor Relations |
| Paolo De Fabritiis | Chief Human Resources Officer |
| Mauro Stocchi | Chief Business Officer |
| Riccardo Butta | President of Americas |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 11, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| May 31, 2024 | SD | Form - SD |
| May 28, 2024 | 6-K | Report of foreign issuer |
| May 24, 2024 | 6-K | Report of foreign issuer |
| May 20, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 16, 2024 | 6-K | Report of foreign issuer |
| May 14, 2024 | 6-K | Report of foreign issuer |
| May 9, 2024 | 6-K | Report of foreign issuer |
| May 9, 2024 | 6-K | Report of foreign issuer |
| May 9, 2024 | 6-K | Report of foreign issuer |